Roche\'s genentech inks potential $2bn personalised cancer drug development deal httpbit.ly2C3peGWÂ pharma Rochepic.twitter.comTa7CuTr3xa
Roche's @genentech inks potential $2bn personalised #cancer drug development deal http://bit.ly/2C3peGW #pharma @Rochepic.twitter.com/Ta7CuTr3xa
More From BioPortfolio on "Roche's @genentech inks potential $2bn personalised #cancer drug development deal http://bit.ly/2C3peGW #pharma @Rochepic.twitter.com/Ta7CuTr3xa"